covid -19大流行期间的透析实践:来自印度的一项调查

IF 0.2 Q4 UROLOGY & NEPHROLOGY
Pallavi Prasad, Ramprasad Elumalai, J. Matcha
{"title":"covid -19大流行期间的透析实践:来自印度的一项调查","authors":"Pallavi Prasad, Ramprasad Elumalai, J. Matcha","doi":"10.34172/jrip.2022.32027","DOIUrl":null,"url":null,"abstract":"INTRODUCTION: We aimed to study the practices being followed in dialysis units across the country during the COVID-19 pandemic. METHODS: A questionnaire assessing treatment and preventive practices being followed in dialysis units during the COVID-19 pandemic was emailed to nephrologists and nephrology trainees practising in India. Responses were recorded electronically. RESULTS: We received 173 valid responses. 83.2% nephrologists were providing dialysis for COVID-19. Hemodialysis/Slow low efficient dialysis was the most common modality (65.2%) of renal replacement therapy (RRT) in COVID-19 acute kidney injury. In dialysis patients with suspicious symptoms, most common test to rule out COVID-19 was RTPCR(reverse transcriptase polymerase chain reaction) +chest imaging ( 42.2%)followed by RT-PCR alone (34.1%). 80.9% nephrologists sought a negative RT-PCR in patients who had recovered from COVID-19 before discontinuation of isolation measures. Adherence to COVID-19 preventive measures varied between 15.2% (portable reverse osmosis disinfection) to 97.1% (mask wearing). Healthcare worker (HCW) training programme was present in 88.4% cases, paid leaves for COVID-19 in 89% and daily HCW symptom screen in 65.3%. The most frequently identified barrier to chronic kidney disease care was a delay in transplantation (66.5%).20.8% reported a temporary closure of dialysis unit due to COVID-19 outbreak. 63% nephrologists counseled patients to choose peritoneal dialysis above hemodialysis as permanent RRT. CONCLUSION: Hemodialysis/SLED is the preferred modality of RRT in COVID 19-AKI.Many nephrologists are counseling for peritoneal dialysis as superior to hemodialysis during COVID-19 for maintenance RRT. Preventive measure adherence is variable across centres. Healthcare worker safety has been addressed in most centres.","PeriodicalId":16950,"journal":{"name":"Journal of Renal Injury Prevention","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"DIALYSIS PRACTICES DURING THE COVID -19 PANDEMIC: A SURVEY FROM INDIA\",\"authors\":\"Pallavi Prasad, Ramprasad Elumalai, J. Matcha\",\"doi\":\"10.34172/jrip.2022.32027\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"INTRODUCTION: We aimed to study the practices being followed in dialysis units across the country during the COVID-19 pandemic. METHODS: A questionnaire assessing treatment and preventive practices being followed in dialysis units during the COVID-19 pandemic was emailed to nephrologists and nephrology trainees practising in India. Responses were recorded electronically. RESULTS: We received 173 valid responses. 83.2% nephrologists were providing dialysis for COVID-19. Hemodialysis/Slow low efficient dialysis was the most common modality (65.2%) of renal replacement therapy (RRT) in COVID-19 acute kidney injury. In dialysis patients with suspicious symptoms, most common test to rule out COVID-19 was RTPCR(reverse transcriptase polymerase chain reaction) +chest imaging ( 42.2%)followed by RT-PCR alone (34.1%). 80.9% nephrologists sought a negative RT-PCR in patients who had recovered from COVID-19 before discontinuation of isolation measures. Adherence to COVID-19 preventive measures varied between 15.2% (portable reverse osmosis disinfection) to 97.1% (mask wearing). Healthcare worker (HCW) training programme was present in 88.4% cases, paid leaves for COVID-19 in 89% and daily HCW symptom screen in 65.3%. The most frequently identified barrier to chronic kidney disease care was a delay in transplantation (66.5%).20.8% reported a temporary closure of dialysis unit due to COVID-19 outbreak. 63% nephrologists counseled patients to choose peritoneal dialysis above hemodialysis as permanent RRT. CONCLUSION: Hemodialysis/SLED is the preferred modality of RRT in COVID 19-AKI.Many nephrologists are counseling for peritoneal dialysis as superior to hemodialysis during COVID-19 for maintenance RRT. Preventive measure adherence is variable across centres. Healthcare worker safety has been addressed in most centres.\",\"PeriodicalId\":16950,\"journal\":{\"name\":\"Journal of Renal Injury Prevention\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-05-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Renal Injury Prevention\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34172/jrip.2022.32027\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Renal Injury Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jrip.2022.32027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

简介:我们旨在研究新冠肺炎大流行期间全国透析单位的做法。方法:将一份评估新冠肺炎大流行期间透析单位治疗和预防措施的问卷通过电子邮件发送给在印度执业的肾病学家和肾病学受训人员。答复以电子方式记录。结果:我们收到173份有效回复。83.2%的肾脏科医生为新冠肺炎提供透析。在新冠肺炎急性肾损伤中,血液透析/慢速低效透析是最常见的肾脏替代治疗(RRT)方式(65.2%)。在有可疑症状的透析患者中,最常见的排除新冠肺炎的检测方法是逆转录聚合酶链式反应(RTPCR)+胸部成像(42.2%),然后是单独的RT-PCR(34.1%)。80.9%的肾科医生在隔离措施中断前对新冠肺炎康复患者进行阴性RT-PCR检测。对新冠肺炎预防措施的遵守率在15.2%(便携式反渗透消毒)到97.1%(戴口罩)之间。88.4%的病例参加了医护人员(HCW)培训计划,89%的患者参加了新冠肺炎带薪休假,65.3%的患者每天进行HCW症状筛查。最常见的慢性肾脏病治疗障碍是移植延迟(66.5%)。20.8%的患者报告称,由于新冠肺炎疫情,透析室暂时关闭。63%的肾科医生建议患者选择腹膜透析而不是血液透析作为永久性RRT。结论:血液透析/SLED是治疗COVID 19-AKI的首选RRT方式。许多肾脏病学家正在为腹膜透析提供咨询,因为在新冠肺炎期间,腹膜透析优于血液透析以维持RRT。各中心对预防措施的遵守情况各不相同。大多数中心都解决了医护人员的安全问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
DIALYSIS PRACTICES DURING THE COVID -19 PANDEMIC: A SURVEY FROM INDIA
INTRODUCTION: We aimed to study the practices being followed in dialysis units across the country during the COVID-19 pandemic. METHODS: A questionnaire assessing treatment and preventive practices being followed in dialysis units during the COVID-19 pandemic was emailed to nephrologists and nephrology trainees practising in India. Responses were recorded electronically. RESULTS: We received 173 valid responses. 83.2% nephrologists were providing dialysis for COVID-19. Hemodialysis/Slow low efficient dialysis was the most common modality (65.2%) of renal replacement therapy (RRT) in COVID-19 acute kidney injury. In dialysis patients with suspicious symptoms, most common test to rule out COVID-19 was RTPCR(reverse transcriptase polymerase chain reaction) +chest imaging ( 42.2%)followed by RT-PCR alone (34.1%). 80.9% nephrologists sought a negative RT-PCR in patients who had recovered from COVID-19 before discontinuation of isolation measures. Adherence to COVID-19 preventive measures varied between 15.2% (portable reverse osmosis disinfection) to 97.1% (mask wearing). Healthcare worker (HCW) training programme was present in 88.4% cases, paid leaves for COVID-19 in 89% and daily HCW symptom screen in 65.3%. The most frequently identified barrier to chronic kidney disease care was a delay in transplantation (66.5%).20.8% reported a temporary closure of dialysis unit due to COVID-19 outbreak. 63% nephrologists counseled patients to choose peritoneal dialysis above hemodialysis as permanent RRT. CONCLUSION: Hemodialysis/SLED is the preferred modality of RRT in COVID 19-AKI.Many nephrologists are counseling for peritoneal dialysis as superior to hemodialysis during COVID-19 for maintenance RRT. Preventive measure adherence is variable across centres. Healthcare worker safety has been addressed in most centres.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Renal Injury Prevention
Journal of Renal Injury Prevention UROLOGY & NEPHROLOGY-
CiteScore
1.60
自引率
0.00%
发文量
36
期刊介绍: The Journal of Renal Injury Prevention (JRIP) is a quarterly peer-reviewed international journal devoted to the promotion of early diagnosis and prevention of renal diseases. It publishes in March, June, September and December of each year. It has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views and renal biopsy teaching point. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at protection/prevention of renal failure and modalities in the treatment of diabetic nephropathy. A further aim of this journal is to emphasize and strengthen the link between renal pathologists/nephropathologists and nephrologists. In addition, JRIP welcomes basic biomedical as well as pharmaceutical scientific research applied to clinical nephrology. Futuristic conceptual hypothesis that integrate various fields of acute kidney injury and renal tubular cell protection are encouraged to be submitted.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信